AXGN

AxoGen Inc.

Price

$44.74

return (12m)

226.09%

p/e

-65.28

p/bv

8.55

DIVIDEND YIELD

0.00%

AXGN price

AxoGen

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AXGN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.72%

3 months

3.06%

1 year

226.09%

2 years

473.96%

5 years

148.97%

10 years

430.09%

Fundamentals AXGN

Valuation

P/E

-65.28

Sector -2.51

Industry 0.28

P/BV

8.55

Sector 2.18

Industry 2.33

P/Revenue (PSR)

8.72

Sector 1.96

Industry 2.32

EV/EBITDA

3,248.15

Sector -24.92

Industry -24.93

EV/EBIT

-1,367.64

Sector -39.41

Industry -29.60

P/EBITDA

-107.95

Sector 0.30

Industry 1.15

P/EBIT

-74.55

Sector -2.09

Industry -0.08

P/Total Assets

7.18

Sector 1.17

Industry 1.27

P/Net Current Assets

14.43

Sector -10.97

Industry -13.00

P/Working Capital

12.88

Sector -4.59

Industry 3.25

EPS

-0.63

Sector -0.91

Industry -0.73

BVPS

4.84

Sector 3.80

Industry 4.57

Efficiency

Gross Margin

74.56%

Sector 44.01%

Industry 49.08%

EBITDA Margin

0.92%

Sector -352.48%

Industry -50.84%

EBIT Margin

-2.18%

Sector -207.71%

Industry -50.45%

Operating Margin

-5.12%

Sector -25.20%

Industry -27.71%

Net Profit Margins

-13.36%

Sector -29.28%

Industry -31.12%

Asset Turnover

0.23

Sector 0.12

Industry 0.14

Profitability

ROE

-13.09%

Sector -36.13%

Industry -40.96%

ROA

-11.01%

Sector -29.39%

Industry -28.52%

ROIC

-5.24%

Sector -439.03%

Industry -97.24%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.60

Sector 1.87

Industry 1.95

Net Debt / EBITDA

-174.08

Sector -1.58

Industry -5.33

Net Debt / EBIT

73.30

Sector -0.83

Industry -1.46

Net Debt / Equity

-0.43

Sector -0.36

Industry -0.31

Gross Debt / Equity

0.00

Sector 0.16

Industry 0.14

Equity/Assets

0.84

Sector 0.42

Industry 0.44

Liabilities/Assets

0.16

Sector 0.46

Industry 0.50

Growth

5Y Revenue CAGR

14.55%

Sector -

Industry -

5Y Earnings CAGR

4.45%

Sector -

Industry -

Fundamentals AXGN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
AXGN	-65.28	8.55	-13.09%	0.00%	$2.19 B	-13.36%
ISRG	39.74	6.82	17.15%	0.00%	$124.72 B	28.45%
ABT	33.60	3.57	10.61%	2.33%	$182.28 B	11.65%
MDT	22.67	2.17	9.59%	3.35%	$108.83 B	13.20%
BSX	16.43	0.00	-%	0.00%	$67.50 B	19.57%
TMDX	14.97	5.21	34.80%	0.00%	$2.57 B	27.04%
IDXX	40.43	28.46	70.38%	0.00%	$44.28 B	24.63%
RMD	19.99	4.68	23.41%	1.15%	$30.37 B	27.44%
SYK	37.03	5.38	14.52%	1.08%	$123.56 B	13.21%
PHG	19.28	1.89	9.80%	3.88%	$24.98 B	6.30%
COHR	104.97	4.47	4.26%	0.00%	$49.22 B	7.10%
INMD	10.92	1.44	13.18%	0.00%	$952.25 M	23.27%
DXCM	31.70	12.09	38.14%	0.00%	$31.69 B	20.12%
EW	49.23	0.00	-%	0.00%	$49.47 B	15.43%
IMRA	64.74	1.13	1.74%	92.47%	$101.64 M	0.00%
BDX	40.36	1.90	4.72%	2.29%	$45.94 B	5.33%
BDXB	8.75	0.54	6.12%	0.00%	$13.76 B	8.36%
ALGN	28.99	2.83	9.77%	0.00%	$11.99 B	9.99%
ABMD	64.27	11.14	17.32%	0.00%	$17.15 B	24.84%
SNN	12.97	2.54	19.61%	2.46%	$13.45 B	8.66%
ZBH	23.79	1.43	6.00%	1.03%	$18.11 B	9.05%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AXGN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	01/27/2010	02/12/2010	1.00000000
Dividends	02/23/2005	03/11/2005	0.05050000

ABOUT AxoGen

AxoGen Inc.

Average Investor10 user rating

4.0 (1 people)

United States

49 years

Founded: 1977

1986

Time since IPO - 40 years

368

Employees

AxoGen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.19 billion, with shareholders equity totaling $256.26 million.

The company employs approximately 368 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, AxoGen Inc. reported $251.17 million in revenue, generating net income of $-33.55 million.

Key financial metrics include a P/E ratio of -65.28, a price-to-book (P/B) ratio of 8.55, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AXGN.

Market cap

$2.19 billion

Net worth

$256.26 million

$256,260,000.00

Assets

$304.86 million

$304,860,000.00

Total Shares Outstanding

53.00 million

53,000,000

Average Daily Trading Volume

$1.31 million

$1,306,252.00

Sector

Health

Industry

Medical Supplies and Equipment

AXGN

AXGN revenue and profits

Financial Results AXGN

DRAG THE FRAME TO SEE MORE DATA

AXGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$96.87 57,32% (12M)

P/E

45.51

2.54%

ROE

3.78%

P/BV

1.72

CI - Cigna

$273.08 3,95% (12M)

P/E

10.87

2.18%

ROE

16.04%

P/BV

1.74

CNC - Centene

$63.36 151,33% (12M)

P/E

-5.98

0.00%

ROE

-22.51%

P/BV

1.35

HUM - Humana

$357.55 41,35% (12M)

P/E

34.70

0.96%

ROE

6.63%

P/BV

2.30

SNY - Sanofi

$42.85 --3,55% (12M)

P/E

6.98

4.12%

ROE

18.43%

P/BV

1.29

HCA - HCA Healthcare

$408.17 12,21% (12M)

P/E

12.92

0.75%

ROE

-213.15%

P/BV

-27.54

LLY - Eli Lilly

$1,175.77 85,04% (12M)

P/E

40.46

0.57%

ROE

81.02%

P/BV

32.78

NVS - Novartis

$153.93 38,26% (12M)

P/E

23.36

1.98%

ROE

30.41%

P/BV

7.11